Octopus (part 2): Introducing the trial with Jeremy Chataway - a podcast by MRC Clinical Trials Unit at UCL

Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recruiting participants for the next few years.

The podcast mini-series will explore the trial from different perspectives by talking to neurologists, MS experts and people affected by MS.Part 2 of the series explores our Octopus trial in depth. Professor Jeremy Chataway, lead investigator of Octopus, discusses its novel design, the treatments it will test, and the criteria for people to take part. He also explains the data researchers will collect and analyse to find out if a treatment is working.
-For more information and to access the transcript: bit.ly/3S6FKP4

For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.ukAs a listener, your opinion is very valuable to us. Please help us to improve the podcast in the future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g

Further episodes of MRC CTU Podcasts

Further podcasts by MRC Clinical Trials Unit at UCL

Website of MRC Clinical Trials Unit at UCL